Guerbet S.A. Stock
Your prediction
Pros and Cons of Guerbet S.A. in the next few years
Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
S********** s********
Cons
?
B****
?
M***** P*******
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Guerbet S.A. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Guerbet S.A. | 0.140% | 8.166% | -0.142% | 114.548% | 82.054% | 0.000% | -35.359% |
Boiron S.A. | -1.900% | 2.849% | 4.733% | -11.140% | -13.602% | -9.379% | -31.331% |
Virbac S.A. | -4.030% | -2.706% | 3.902% | 20.436% | 0.139% | 28.164% | 131.637% |
Onxeo S.A. | -1.750% | 5.360% | 16.803% | -61.745% | -24.752% | -83.830% | -86.064% |
News
Guerbet: Change in Guerbet’s Board of Directors.
Guerbet: Change in Guerbet’s Board of Directors.
Guerbet: 2023 full-year results.
Guerbet: 2023 full-year results.
Guerbet strengthens its Executive Committee with two new appointments to consolidate its medium and long-term ambitions.
Guerbet strengthens its Executive Committee with two new appointments to consolidate its medium and long-term ambitions.